Indoco Remedies: Exports Drive Growth; Domestic Yet To Normalise, Says ICICI Direct 
Tablets fall into a collection bin inside a pharmaceutical plant in Goa. (Photographer: Dhiraj Singh/Bloomberg)

Indoco Remedies: Exports Drive Growth; Domestic Yet To Normalise, Says ICICI Direct 

Bookmark

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Amid strong recovery in the export business, the company’s overall revenues grew 10.8% to Rs 604 crore. Domestic market growth was subdued amid Covid-19.

Ebitda margins improved 800 basis points to 18.1% mainly due to better product mix and lower travel and promotional expenses.

Subsequent Ebitda grew 98.7% YoY to Rs 109.7 crore. Net profit for first half of the year came in at Rs 42.7 crore (up 342% YoY) versus Rs 9.7 crore in H1 FY20.

Click on the attachment to read the full report:

ICICI Direct Indoco Company Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.